Daniell Richard
CIK 0001726096
Exec. VP, European Commercial
Filings
22
Latest May 7, 2026
Issuers covered
1
Showing
22 of 22
Page 1
Track record
33 of 33 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 33 | 67% | +1.0% | +5.4% | +16.8% | -37.1% |
| 90 days | 32 | 16% | -6.8% | -8.1% | +27.2% | -28.0% |
| 180 days | 25 | 16% | -18.7% | -19.2% | +3.5% | -42.1% |
| 365 days | 25 | 4% | -56.0% | -32.8% | +2.8% | -109.8% |
Issuers
Companies where Daniell Richard has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Ltd | 22 | May 7, 2026 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|